Abstract
Background
Parkinsonian patients with excessive daytime sleepiness (EDS), hallucinations, REM sleep behavior disorder (RBD), short mean sleep latencies, and sleep-onset REM periods (SOREMP) on multiple sleep latency tests (MSLT) have been reported. In these patients a narcolepsy-like pathophysiology of sleep-wake disturbances has been suggested.
Patients and methods
We studied 14 consecutive patients with Parkinsonism and EDS. Standard studies included assessment of duration and severity of Parkinsonism (Hoehn & Yahr score), Epworth sleepiness score (ESS), history of “REM-symptoms” (RBD/hallucinations/sleep paralysis/cataplexy-like episodes), polysomnography (PSG),MSLT, and measurement of cerebrospinal fluid (CSF) levels of hypocretin-1 (orexin A).
Results
There were 12 men and 2 women (mean age 69 years; range 54–82). The mean duration and the Hoehn & Yahr score were 6.3 years and 2.2, respectively. Diagnoses included idiopathic Parkinson’s disease (IPD, n=10), dementia with diffuse Lewy bodies (n=3), and multisystem atrophy (n=1). The ESS was ≥10 in all patients (mean 12; range 10–18). “REM-symptoms” were reported by all but two patients (hallucinations: n=9; RBD: n=9).None of the patients reported cataplexy-like symptoms or sleep paralysis. On PSG sleep apnea (apnea hypopnea index > 10/h, n=7), periodic limb movements during sleep (PLMS-index > 10/h, n=6), and features of RBD (n=5) were found. On MSLT mean sleep latency was < 5 minutes in 10 patients, and SOREMP were found in two patients. When compared with controls (n=20, mean 497 pg/ml; range 350–603), CSF hypocretin-1 levels were normal in 8 patients and low in 2 patients (221 and 307 pg/ml, respectively).
Conclusion
These findings do not support the hypothesis of a “final common pathway” in the pathophysiology of narcolepsy and Parkinsonism with EDS. Sleep apnea and PLMS may play a so-far underestimated role in the pathogenesis of EDS in Parkinsonian patients.
Similar content being viewed by others
References
Rye DB, Bliwise DL, Dihenia B, Gurecki P (2000) Daytime sleepiness in Parkinson’s disease. J Sleep Res 9:63–69
Tandberg E, Larsen JP, Karlsen K (1999) Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: A community-based study. Mov Dis 14:922–927
Högl B, Seppi K, Brandauer E, Glatzl S, Frauscher B, Niedermuller U, et al. (2003) Increased daytime sleepiness in Parkinson’s disease: A questionnaire survey. Mov Dis 18:319–323
Roth T, Rye D, Borchen LD, et al. (2003) Assessment of sleepiness and unintended sleep in Parkinson’s disease patients taking dopamine agonists. Sleep Med 4:275–280
Hobson DE, Lang AE, Wayne Martin WR, Razmy A, Rivest J, Fleming JA (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson’s disease. JAMA 287:455–463
Brodsky MA, Goldbold J, Roth T, Olanow CW (2003) Sleepiness in Parkinson’s disease: A controlled study. Mov Dis 18:668–672
Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J (2001) Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology 57:1392–1395
Tan EK, Lum SY, Fook-Chong SMC, et al. (2002) Evaluation of somnolence in Parkinson’s disease: Comparison with age- and sex-matched controls. Neurology 58:465–468
Arnulf I, Konofal E, Merino-Andreu M, et al. (2002) Parkinson’s disease and sleepiness: an integral part of PD. Neurology 58:1019–1024
Paus S, Brecht HM, Köster J, Seegr G, Klockgether T, Wüllner U (2003) Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease. Mov Dis 18:659–667
Arnulf I, Bonnet AM, Damier P, et al. (2000) Hallucinations, REM sleep, and Parkinson’s disease. A medical hypothesis. Neurology 55:281–288
Sanchez-Ramos JR, Ortoll R, Paulson GW (1996) Visual hallucinations associated with Parkinson disease. Arch Neurol 53:1265–1268
Fénelon G, Mahieux F, Huon R, Ziégler M (2000) Hallucinations in Parkinson’s disease. Brain 123:733–745
Ferman TJ, Smith GE, Boeve BF, et al. (2004) DLB fluctuations. Specific features that reliably differentiate DLB from AD and normal aging. Neurology 62:181–187
Gagnon JF, Bédard MA, Fantini ML, Petit D, Panisset M, Rompré S, et al. (2002) REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology 59:585–589
Trenkwalder C, Collado-Seidel V, Pollmächer T, et al. (1998) Sleep in patients with untreated Parkinson’s disease and multiple system atrophy compared to normal controls. Neurology 50:A393
Arnulf I, Beijani BP, et al. (2000) Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology 55:1732–1734
Mignot E, Lammers GJ, Ripley B, Okun ML, Nevsimalova S, Overeem S, et al. (2002) The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59:1553–1562
Dauvilliers Y, Baumann CR, Maly FE, Billiard M, Bassetti C (2003) CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 74:1667–73
Overeem N, Van Hilten JJ, Ripley B, Mignot E, Nishino H, Lammers C (2002) Normal hypocretin-1 levels in Parkinson’s disease patients with excessive daytime sleepiness. Neurology 58:498–499
Ripley B, Overeem N, Fujiki N, Nevsimalova S, Uchino M, Yesavage J, et al. (2001) CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57:2253–2258
Kanbayashi T, Kawanishi K, Ishiguro H, et al. (2002) CSF hypocretin concentration in various neurologic disorders and sleep apnea syndromes (abstract) 25(Suppl):A496
Drout X, Moutereau S, Nguyen JP, Lefaucheur JP, Creange JP, Remy P, et al. (2003) Low levels of ventricular CSF orexin/hypocretin in advanced Parkinson’s disease. Neurology 61:540
Hughes AJ, Saniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47:1113–1124
Johns MW (1994) Sleepiness in different situations measured by the Epworth sleepiness scale. Sleep 17:703–710
American Sleep Disorders A (1997) International Classification of Sleep Disorders: diagnostic and coding manual, revised. Rochester, MN
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12:189–198
Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service: Brain Research Institute
Baumann CR, Dauvilliers Y, Mignot E, Bassetti CL (2004) Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness. Eur Neurol (in press)
Rye DB (1997) Contributions of the pe-dunculopontine region to normal and altered REM sleep. Sleep 20:757–788
Rye DB, Jankovic J (2002) Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 58:341–346
Rye D, Johnston L,Watts R, Bliwise D (1999) Juvenile Parkinsons’ disease with REM sleep behavior disorder, sleepiness and daytime REM-onsets. Neurology 53:1868–1870
Arnulf I, Milagros MA, Konofal E, et al. (2002) Excessive daytime sleepiness and sleep-disordered breathing in patients with progressive supranuclear palsy. Neurology 58(Suppl 3):A163
Bliwise D, Williams M, Irbe D,Ansari F, Rye D (2000) Inter-rater reliability for identification of REM sleep in Parkinson’s disease. Sleep 23:671–676
Homann CN, Wenzel K, Duppan K, Kriechbaum N, Crevenna R, Ott E (2002) Sleep attacks in patients taking dopamine agonists: review. BMJ 324:1483–1487
Bassetti C, Clavadetscher S, Gugger M, Hess CW (2002) Pergolide-associated “sleep attacks” in a patient with restless legs syndrome. Sleep Med 3:275–277
Razmy A, Lang AE, Shapiro CM (2004) Predictors of impaired daytime sleep and wakefulness in patients with Parkinson’s disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 61:97–102
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baumann, C., Ferini-Strambi, L., Waldvogel, D. et al. Parkinsonism with excessive daytime sleepiness. J Neurol 252, 139–145 (2005). https://doi.org/10.1007/s00415-005-0614-5
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0614-5